Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2026-02-24 @ 5:07 AM
Study NCT ID:
NCT03146650
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-18
First Post:
2017-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
Sponsor:
Northwestern University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-19
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-11
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-05
First Submit QC Date:
None
Study First Post Date:
2017-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-21
Results First Submit QC Date:
None
Results First Post Date:
2024-01-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-21
Last Update Post Date:
2024-01-18
Last Update Post Date Type:
ACTUAL